The contemporary management of cancers of the sinonasal tract in adults

R Thawani, MS Kim, A Arastu, Z Feng… - CA: a cancer journal …, 2023 - Wiley Online Library
Sinonasal malignancies make up< 5% of all head and neck neoplasms, with an incidence of
0.5–1.0 per 100,000. The outcome of these rare malignancies has been poor, whereas …

Mucosal melanoma: a literature review

SS Yde, P Sjoegren, M Heje, LB Stolle - Current oncology reports, 2018 - Springer
Purpose of review Mucosal melanoma is of great interest due to its aggressive behavior and
less favorable prognosis. The literature is mainly case reports and case series. Here, we will …

Mucosal melanoma of the head and neck

PA Ascierto, R Accorona, G Botti, D Farina… - Critical reviews in …, 2017 - Elsevier
Mucosal melanoma of the head and neck is a very rare and aggressive malignancy with a
very poor prognosis. The nasal cavity, paranasal sinuses, and oral cavity are the most …

[HTML][HTML] Mucosal melanoma: pathological evolution, pathway dependency and targeted therapy

Y Ma, R Xia, X Ma, RL Judson-Torres, H Zeng - Frontiers in Oncology, 2021 - frontiersin.org
Mucosal melanoma (MM) is a rare melanoma subtype that originates from melanocytes
within sun-protected mucous membranes. Compared with cutaneous melanoma (CM), MM …

[HTML][HTML] Unusual clinical presentations of malignant melanoma: a review of clinical and histologic features with special emphasis on dermatoscopic findings

R Cabrera, F Recule - American journal of clinical dermatology, 2018 - Springer
This review presents the main challenges encountered when diagnosing unusual variants of
malignant melanoma with the aim of raising awareness to allow application of the most …

The role of systemic therapy in the management of sinonasal cancer: a critical review

P Bossi, NF Saba, JB Vermorken, P Strojan… - Cancer treatment …, 2015 - Elsevier
Purpose Due to the rarity and the variety of histological types of sinonasal cancers, there is a
paucity of data regarding strategy for their optimal treatment. Generally, outcomes of …

[HTML][HTML] PRAME expression in mucosal melanoma of the head and neck region

C Ricci, MV Altavilla, B Corti, E Pasquini… - The American Journal …, 2023 - journals.lww.com
PRAME (PReferentially expressed Antigen in MElanoma), a cancer-testis antigen expressed
in normal and neoplastic tissues with several functions, proved to be a useful diagnostic tool …

[HTML][HTML] Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

U Keilholz, JM Mehnert, S Bauer, H Bourgeois… - … for immunotherapy of …, 2019 - Springer
Background We report phase 1b data from patients enrolled in the JAVELIN Solid Tumor
clinical trial (NCT01772004) with unresectable stage IIIC or IV melanoma that had …

[HTML][HTML] Treatment of canine oral melanomas: a critical review of the literature

P Pazzi, G Steenkamp, AJ Rixon - Veterinary Sciences, 2022 - mdpi.com
Critical appraisal of the available literature for the treatment of canine oral malignant
melanoma (OMM) is lacking. This critical review aimed to evaluate the current literature and …

Update from the 4th edition of the World Health Organization classification of head and neck tumours: mucosal melanomas

MD Williams - Head and neck pathology, 2017 - Springer
The updated edition of The World Health Organization Classification of Tumours of the Head
and Neck includes discussions on mucosal melanoma of both the sinonasal and oral cavity …